| |
| Issue |
Title |
| |
| Vol 13, No 4 (2024) |
Prospects for optimizing the provision of medicines to pediatric patients based on the development of the pharmaceutical market in the segment of medicines for children |
Abstract
PDF (Rus)
|
|
O. D. Nemyatykh, E. A. Kovaleva, I. A. Narkevich |
| |
| Vol 13, No 2 (2024) |
Outdated latin names of medicinal plants in the monographs of the State Pharmacopoeia of the Russian Federation, XIV edition (review) |
Abstract
PDF (Rus)
|
|
M. N. Povydysh, M. Yu. Goncharov |
| |
| Vol 13, No 1 (2024) |
Affect of Features of a Microorganism Strain on a Scope of Exclusive Rights |
Abstract
PDF (Rus)
|
|
F. S. Ivanov, K. V. Nasonova |
| |
| Vol 12, No 4 (2023): Supplement 1 |
Scientific, Methodological and Organizational Approaches to Conducting Pre-clinical and Expert studies of Substances with Psychoactive Properties |
Abstract
PDF (Rus)
|
|
T. L. Malkova, P. S. Mashchenko, A. I. Andreev, D. Yu. Apushkin, E. V. Vikhareva |
| |
| Vol 12, No 4 (2023): Supplement 1 |
Creation of a Scientific System for Analyzing the Scientific Activities of a University as a Source of Innovation in the Production of Medicines |
Abstract
PDF (Rus)
|
|
E. V. Sokolova, P. S. Guryanov, A. G. Salnikova, T. L. Malkova |
| |
| Vol 12, No 3 (2023) |
Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products |
Abstract
PDF (Rus)
|
|
A. A. Taube, N. Yu. Velts |
| |
| Vol 12, No 2 (2023) |
Regulation of the Launch of Orphan Drugs on the Market of the Eurasian Economic Union as a Mechanism to Increase the Availability of Treatment for Rare Diseases (Review) |
Abstract
PDF (Rus)
|
|
A. V. Foteeva, N. A. Koneva, O. S. Beloglazova, N. B. Rostova |
| |
| Vol 12, No 1 (2023) |
About Analytical and Technological Reasons of Out-of-Specification Results for Assay and Disolution Tests (Review) |
Abstract
PDF (Rus)
|
|
N. A. Epshtein |
| |
| Vol 11, No 4 (2022): Supplement 1 |
Destruction of Narcotic Drugs and Psychotropic Substances as a Stage of Circulation of Medicines |
Abstract
PDF (Rus)
|
|
T. L. Malkova, E. S. Berezina |
| |
| Vol 11, No 4 (2022): Supplement 1 |
On the Issue of the Effectiveness of the Department for Registration of Medicines |
Abstract
PDF (Rus)
|
|
A. V. Foteeva, N. A. Koneva, N. B. Rostova |
| |
| Vol 11, No 4 (2022): Supplement 1 |
On the Formation of Professionally Specialized Competencies and Training of Specialists and Managers in the Pharmacovigilance System of the Marketing Authorization Holder |
Abstract
PDF (Rus)
|
|
E. Yu. Kurganova, A. V. Soloninina |
| |
| Vol 11, No 3 (2022) |
Issues of National Drug Security in Formation of a Reserve of Antibacterial Agents Intended to Eliminate Medical and Sanitary Consequences of Emergencies |
Abstract
PDF (Eng)
|
|
L. Yu. Chernikova, V. N. Dmitruk, N. L. Denisov, E. G. Morozova, A. V. Ratkin, E. V. Karakulova |
| |
| Vol 11, No 1 (2022) |
Systematic approach to cross-contamination risk management in the production of medicinal products |
Abstract
PDF (Rus)
|
|
A. A. Dzerzhinskaya, A. A. Spiridonova, E. G. Khomutova |
| |
| Vol 11, No 1 (2022) |
Mutual Recognition Procedure for the Registration of Medicines: New Challenges or Opportunities |
Abstract
PDF (Rus)
|
|
A. V. Foteeva, O. S. Barshadskaya, N. B. Rostova |
| |
| Vol 11, No 1 (2022) |
Organization of Hygienic Monitoring of Working Area Air Pollution by Particulates in Pharmaceutical Industries (Review) |
Abstract
PDF (Rus)
|
|
I. A. Pozharnov, A. S. Simakov, A. A. Shatilina, G. V. Ramenskaya |
| |
| Vol 10, No 4 (2021) |
The Use of Digital Technologies for the Purpose of Improving Methodological Approaches to the Creation of a Pharmaceutical Quality System at Enterprises for the Production of Medicines |
Abstract
PDF (Rus)
|
|
V. V. Goryachkin, V. А. Smirnov, V. N. Shestakov, R. A. Abramovich |
| |
| Vol 10, No 4 (2021) |
Alternative Methods for Dissolution Profile Comparison in the Dissolution Test |
Abstract
PDF (Rus)
|
|
D. P. Romodanovsky, D. V. Goryachev |
| |
| Vol 10, No 3 (2021) |
Scaling of the Granulation Process in the Conditions of GMP Training Center and Assessment of Possible Risks |
Abstract
PDF (Rus)
|
|
O. N. Abrosimova, M. A. Burakova |
| |
| Vol 10, No 3 (2021) |
The Integrated Model of Quality Management System of Laboratory Studies of Medicines (Review) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. I. Selezneva, V. A. Smirnov, V. V. Goryachkin, N. N. Chadova, S. V. Polyakov, V. N. Shestakov, R. A. Abramovich |
| |
| Vol 10, No 3 (2021) |
Procedure for Reviewing Pharmaceutical Inspections in the Eurasian Economic Union (Review) |
Abstract
PDF (Rus)
|
|
A. P. Meshkovskiy, V. V. Beregovykh, V. N. Shestakov, N. V. Pyatigorskaya, Zh. I. Aladysheva, N. S. Nikolenko, A. M. Pyatigorskiy, E. I. Nesterkina |
| |
| Vol 10, No 3 (2021) |
Labeling of Immunobiological Drugs, Produced by the Russian Research An-ti-Plague Institution "Microbe" of the Rospotrebnadzor (Review) |
Abstract
PDF (Rus)
|
|
A. V. Komissarov, O. A. Lobovikova, I. V. Shul'gina, V. S. Kostyuchenko, E. G. Abramova, O. A. Volokh, N. V. Sinitsyna, V. A. Demchenko, A. S. Fes'kova, A. K. Nikiforov |
| |
| Vol 10, No 2 (2021) |
Transfer of Impurities Determination Methods: Comparative Testing, Validation, Acceptance Criteria (Review) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
N. A. Epshtein |
| |
| Vol 10, No 2 (2021) |
Documentation of Pharmaceutical Development. Part 2. Quality System Documents |
Abstract
PDF (Rus)
|
|
I. E. Smekhova, L. V. Shigarova, I. A. Narkevich, E. V. Flisyuk, V. D. Meteleva |
| |
| Vol 10, No 2 (2021) |
Description of the System of State Registration of Medicines in the Republic of Georgia as a Development Potential of Domestic Manufacturers |
Abstract
PDF (Rus)
|
|
A. V. Foteeva, O. S. Barshadskaya, N. B. Rostova |
| |
| Vol 10, No 2 (2021) |
The History of the Creation of the VII State Pharmacopoeia of the USSR (Review) |
Abstract
PDF (Rus)
|
|
K. S. Guzev |
| |
| Vol 10, No 1 (2021) |
Guidelines for Promoting the Implementation of Pharmaceutical Quality Systems at EAEU Enterprises Through the Management of the Engagement of Production Personnel |
Abstract
PDF (Rus)
|
|
V. A. Smirnov, V. V. Goryachkin, V. N. Shestakov, R. A. Abramovich |
| |
| Vol 10, No 1 (2021) |
Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site |
Abstract
PDF (Rus)
|
|
I. E. Smekhova, L. V. Shigarova, V. D. Meteleva, E. V. Flisyuk |
| |
| Vol 10, No 1 (2021) |
Development of Retraining Systems for the Implementation of the Pharmaceutical Quality System at Pharmaceutical Production Enterprises of the EAEU Countries |
Abstract
PDF (Rus)
|
|
V. A. Smirnov, V. V. Goryachkin, V. N. Shestakov, R. A. Abramovich |
| |
| Vol 9, No 4 (2020) |
N-nitrosamine Impurities in Medicines: Toxicity, Formation Pathways, Methods of Determination, and Limits (Review) |
Abstract
PDF (Rus)
|
|
P. P. Shchetinin, S. P. Senchenko, K. K. Gordeev |
| |
| Vol 9, No 4 (2020) |
The Modern Concepts of Pharmaceutical Development in the Context of the Transition to a Uniform Regulation of Medicinal Products Circulation |
Abstract
PDF (Rus)
|
|
A. E. Feofilova, A. V. Foteeva, N. B. Rostova |
| |
| Vol 9, No 4 (2020) |
Responsibilities of the Marketing Authorisation Holders in Respect of GMP Compliance (Review) |
Abstract
PDF (Rus)
|
|
A. P. Meshkovskiy, N. V. Pyatigorskaya, Z. I. Aladysheva, V. V. Beregovykh, A. M. Pyatigorskiy, N. S. Nikolenko, M. M. Marshalova, V. V. Belyaev |
| |
| Vol 9, No 3 (2020) |
Evaluation of New Risk-based Regulatory Approach to Classification of GMP Deficiencies (Review) |
Abstract
PDF (Rus)
|
|
V. N. Shestakov, Yu. V. Podpruzhnikov |
| |
| Vol 9, No 3 (2020) |
Metrological Requirements to Measuring Equipment (Review) |
Abstract
PDF (Rus)
|
|
N. V. Shineva, M. V. Gavrilin, Yu. A. Starchak, S. V. Makarov |
| |
| Vol 9, No 3 (2020) |
Transfer of Analytical Procedures (Review) |
Abstract
PDF (Rus)
|
|
Yu. A. Starchak, M. V. Gavrilin, N. V. Shineva |
| |
| Vol 9, No 2 (2020) |
Assessing the Correlation Between GMP Deviations and Potential Quality Defects of Medicinal Products: the Result of the Survey of Qualified Persons |
Abstract
PDF (Rus)
|
|
V. A. Orlov, V. N. Shestakov |
| |
| Vol 9, No 1 (2020) |
Review of Post-registration Changes in the Life Cycle of Сholera Bivalent Chemical Vaccine (Review) |
Abstract
PDF (Rus)
|
|
I. V. Shulgina, O. A. Lobovikova, O. A. Voloh, O. V. Gromova, A. K. Nikiforov, A. V. Komissarov, V. A. Demchenko, A. S. Fes’kova, S. S. Galetova, N. P. Mironova, V. I. Pavlova |
| |
| Vol 8, No 3 (2019) |
Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products |
Abstract
PDF (Rus)
|
|
A. L. Khokhlov, D. P. Romodanovsky, A. E. Miroshnikov |
| |
| Vol 8, No 2 (2019) |
Validation of Analytical Procedures: Graphic and Calculated Criteria for Assessment of Methods Linearity in Practice |
Abstract
PDF (Rus)
|
|
N. A. Epshtein |
| |
| Vol 8, No 1 (2019) |
REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW) |
Abstract
PDF (Rus)
|
|
O. A. Lobovikova, I. V. Shul'gina, E. G. Abramova, A. K. Nikiforov, A. V. Komissarov, V. A. Demchenko, A. G. Selezneva, A. S. Fes'kova, S. S. Galetova, N. P. Mironova |
| |
| Vol 8, No 1 (2019) |
USE OF SIBUTRAMIN IN PHARMACEUTICAL DRUGS AND ANOREXIC DIETARY SUPPLEMENTS (REVIEW) |
Abstract
PDF (Rus)
|
|
A. M. Sukhanova, I. B. Perova, G. M. Rodionova, K. I. Eller, V. I. Gegechkori |
| |
| Vol 8, No 1 (2019) |
THE PROGRAM OF ADAPTATION AND PROFESSIONAL DEVELOPMENT OF PERSONNEL WITHIN A QUALITY MANAGEMENT SYSTEM OF THE PHARMACEUTICAL ORGANIZATION (REVIEW) |
Abstract
PDF (Rus)
|
|
N. G. Zolotareva, S. V. Strelkov, V. A. Strelkova |
| |
| Vol 8, No 1 (2019) |
CHROMATOGRAPHIC SYSTEM SUITABILITY TESTING: INFLUENCE OF CORRECTION FACTORS AND LATE ELUTING PEAKS OF IMPURITIES ON THE REQUIREMENT FOR THE SIGNAL-TO-NOISE RATIO (REVIEW) |
Abstract
PDF (Rus)
|
|
N. A. Epshtein |
| |
| Vol 8, No 1 (2019) |
CERTIFICATION OF QUALITY MANAGEMENT SYSTEM OF LLC «CENTER OF PHARMACEUTICAL ANALYTICS» ACCORDING TO THE REQUIREMENTS OF ISO 9001:2015 (GOST R ISO 9001-2015) (REVIEW) |
Abstract
PDF (Rus)
|
|
A. A. Krylatova, I. E. Shohin, E. P. Obrazcova |
| |
| No 1 (2016) |
POTENT NON-NARCOTIC ANALGESICS AS А DIRECTION IN DEVELOPMENT OF PHARMACEUTICALS |
Abstract
PDF (Rus)
|
|
A. V. Sosnov, S. V. Sadovnikov, F. M. Semchenko, K. A. Rufanov, V. N. Tohmahchi, A. A. Sosnova, I. A. Tyurin |
| |
| No 2 (2017) |
THE ANALYSIS OF THE PHARMACEUTICAL MARKET ON THE EXAMPLE OF MEDICINES OF GROUP OF INHIBITORS OF THE PROTON POMP |
Abstract
PDF (Rus)
|
|
N. V. Mazova, A. L. Marchenko, N. V. Marchenko |
| |
| No 4 (2018) |
THE ROLE OF THE SCIENTIFIC OVERVIEWS IN THE GENERIC DRUG REGISTRATION PROCESS IN THE RUSSIAN FEDERATION AND EURASIAN ECONOMIC UNION |
Abstract
PDF (Rus)
|
|
K. S. Milchakov |
| |
| No 1 (2016) |
THE PROCEDURE OF ACTIVE PHARMACEUTICAL INGREDIENT SUPPLIERS PRELIMINARY CHOICE FOR MEDICINE MANUFACTURE |
Abstract
PDF (Rus)
|
|
S. A. Zaitsev, A. V. Basevich, A. O. Hrustaleva |
| |
| No 2 (2017) |
PROBLEMS OF CONFORMITY OF THE RECORDS INTEGRITY WITH THE REQUIREMENTS OF GOOD MANUFACTURING PRACTICE. REPORT 1. ACTUALITY OF THE RECORDS INTEGRITY CONSERVATION |
Abstract
PDF (Rus)
|
|
I. A. Osmolovskaya, O. V. Zarochinskaya, M. O. Emelianov, D. V. Somov |
| |
| No 1 (2016) |
REFERENCE STANDARDS OF ACTIVE INGREDIENTS OF POTENT ANALGESIC DRUGS |
Abstract
PDF (Rus)
|
|
A. V. Sosnov, S. S. Golubev, B. S. Punkevich, S. V. Sadovnikov, E. M. Zagrebin, I. S. Rodina, F. M. Semchenko, A. A. Sosnova |
| |
| No 3 (2017) |
ANALYSIS OF THE SYSTEM ORGANIZATION OF PHARMACEUTICAL DRUG DEVELOPMENT |
Abstract
PDF (Rus)
|
|
S. A. Rozhnova, A. V. Tsypkina |
| |
| No 1 (2016) |
RISK ANALYSIS OF THE DEFICIENCIES FOUND BY THE GMP INSPECTIONS |
Abstract
PDF (Rus)
|
|
Yu. V. Podpruznikov, V. N. Shestakov |
| |
| No 3 (2017) |
TABLETS. REGULATORY REQUIREMENTS OF THE STATE PHARMACOPOEIA XIII EDITION |
Abstract
PDF (Rus)
|
|
N. V. Isaeva, A. I. Tulaykin, E. V. Sheshegova |
| |
| No 1 (2016) |
ESTABLISHMENT OF FEATURES DESCRIPTION OF OBJECT GOVERNMENT PROCUREMENT «MEDICINAL PRODUCTS» AS A CONDITION OF GRANTING PREFERENCES TO LOCAL PRODUCERS |
Abstract
PDF (Rus)
|
|
I. A. Narkevitch, Z. M. Golant, N. S. Kartashova |
| |
| No 4 (2017) |
MULTIPLE VIEW MARKETING ANALYSIS OF THE RUSSIAN PLANT-BASED DRUGS MARKET |
Abstract
PDF (Rus)
|
|
A. V. Akamova, O. D. Nemyatykh, I. A. Narkevich |
| |
| No 3 (2016) |
THE ROLE OF REFERENCE STANDARDS IN QUALITY ASSURANCE FOR MEDICINES: REGULATORY AND METROLOGICAL ASPECTS |
Abstract
PDF (Rus)
|
|
D. A. Leontiev, Y. V. Podpruzhnikov, N. V. Volovyk |
| |
| No 4 (2017) |
GLOBAL PHARMACEUTICAL MARKET TRENDS: OPPORTUNITIES FOR DEVELOPMENT |
Abstract
PDF (Rus)
|
|
D. A. Demidyonok, T. A. Petrova, I. A. Narkevich, V. A. Markova |
| |
| No 3 (2016) |
THE PROSPECTS OF THE USING OF THE REGISTER OF THE STANDARD LABELS OF THE INTERCHANGEABLE MEDICINES TO IMPROVE OF DRUG SUPPLY OF PEDIATRIC PATIENTS |
Abstract
PDF (Rus)
|
|
G. Ia. Ibragimova, A. Kh. Gaisarov, R. V. Nasyrov |
| |
| No 4 (2017) |
THE DEVELOPMENT OF THE FUNCTIONAL MODEL OF THE CONDUCTING ACTIVITIES IN PHARMACIES FOR IMPLEMENTATION OF PHARMACOVIGILANCE |
Abstract
PDF (Rus)
|
|
G. Ia. Ibragimova, A. Kh. Gaisarov |
| |
| No 3 (2016) |
PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES |
Abstract
PDF (Rus)
|
|
I. A. Narkevich, O. D. Nemyatykh, I. I. Basakina, D. D. Siukaeva |
| |
| No 4 (2017) |
COMPREHENSIVE ASSESSMENT OF THE MARKET DRUGS FOR TREATMENT OF PNEUMONIA IN PEDIATRICS |
Abstract
PDF (Rus)
|
|
D. D. Siukaeva, O. D. Nemyatyh, I. A. Narkevich, N. I. Pavlenko |
| |
| No 3 (2016) |
REVIEW, CHARACTERISTICS AND ANALYSIS OF THE LAST CHANGES IN THE GMP REQUIREMENTS |
Abstract
PDF (Rus)
|
|
Yu. V. Podpruznikov, V. N. Shestakov |
| |
| No 1 (2018) |
COMPARATIVE ANALYSIS OF THE DOMESTIC AND FOREIGN PHARMACEUTICAL MARKETS FOR THE NOSE WITH THE PURPOSE OF SEARCHING FOR FUTURE DEVELOPMENT PROSPECTS |
Abstract
PDF (Rus)
|
|
M. Yu. Kinev, A. Yu. Petrov |
| |
| No 1 (2017) |
PARTICIPANTS OF THE «COLD CHAIN»: ANALYSIS OF COMPLIANCE WITH THE RULES OF THE GDP |
Abstract
PDF (Rus)
|
|
I. A. Narkevich, V. A. Markova, D. A. Demidyonok |
| |
| No 1 (2018) |
CERTIFICATION FOR THE CONFORMITY OF ISO 9001 EQUIREMENTS AS A FIRST PHASE OF IMPLEMENTATION OF GOOD LABORATORY PRACTICE IN THE CENTER OF EXPERIMENTAL PHARMACOLOGY |
Abstract
PDF (Rus)
|
|
I. A. Narkevich, E. V. Flisyuk, A. V. Moskvin, L. V. Shigarova, D. Y. Ivkin, A. S. Ivkina |
| |
| No 2 (2016) |
TOPICAL ISSUES OF TRAINING OF GMP INSPECTORS |
Abstract
PDF (Rus)
|
|
V. N. Shestakov, Yu. V. Podpruzhnikov |
| |
| No 1 (2017) |
THE ROLE OF SMALL INNOVATIVE ENTERPRISES IN THE DEVELOPMENT AND MARKET LAUNCH OF INNOVATIVE DRUGS |
Abstract
PDF (Rus)
|
|
A. A. Semin, I. A. Narkevich |
| |
| No 2 (2018) |
OVERVIEW OF GMP INSPECTIONS RESULTS OF FOREIGN MANUFACTURING SITES IN 2017 |
Abstract
PDF (Rus)
|
|
V. A. Orlov |
| |
| No 2 (2016) |
ASSESSMENT OF THE RUSSIAN FEDERATION REQUIREMENT IN POTENT ANALGESICS |
Abstract
PDF (Rus)
|
|
A. V. Sosnov, S. S. Golubev, B. S. Punkevich, S. V. Sadovnikov, F. M. Semchenko, V. N. Tohmahchi, A. A. Sosnova |
| |
| No 1 (2017) |
AN OVERVIEW OF THE MAIN CHANGES IN THE RULES OF GOOD LABORATORY PRACTICE (THE ORDER FROM 01 APRIL 2016 № 199n ENTERED INSTEAD OF THE ORDER OF MINISTRY OF HEALTH OF 23 AUGUST 2010 №708n) |
Abstract
PDF (Rus)
|
|
M. S. Zhuravleva, M. V. Lebedeva |
| |
| No 2 (2018) |
POTENTIAL OF THE RUSSIAN FEDERATION IN EXPORTS OF ANTI-INFLUENZA VACCINES IN LATIN AMERICAN COUNTRIES |
Abstract
PDF (Rus)
|
|
V. P. Trukhin, I. A. Narkevich, E. P. Nacharova, S. V. Uiba, I. I. Basakina |
| |
| No 2 (2016) |
TERM EXTENSION OF DRUG PATENTS IN RUSSIA (REVIEW OF LEGISLATION AMENDMENTS) |
Abstract
PDF (Rus)
|
|
K. V. Osipov |
| |
| No 1 (2017) |
PHARMACEUTICAL CO-CRYSTALLS. FEATURES OF ASSESING THE PATENTABILITY |
Abstract
PDF (Rus)
|
|
S. A. Sinchenko |
| |
| No 2 (2018) |
COMPREHENSIVE MARKETING STUDY OF THE RUSSIAN PHARMACEUTICAL MARKET DRUGS FOR PREVENTION AND TREATMENT OF DISEASES OF THE THYROID GLAND |
Abstract
PDF (Rus)
|
|
V. I. Zvereva, O. A. Semkina, E. I. Gribkova |
| |
| No 2 (2016) |
COMPARISON OF RUSSIAN AND FOREIGN HYGIENIC PARAMETERS OF MEDICINES PERMISSIBLE EXPOSURE LIMIT |
Abstract
PDF (Rus)
|
|
S. S. Rozhkov, A. V. Smirnov |
| |
| No 2 (2017) |
ANALYTICAL REVIEW OF THE NORMATIVE BASE TO PROVIDE THE GOOD QUALITY OF PRECLINICAL STUDIES IN RUSSIA |
Abstract
PDF (Rus)
|
|
A. I. Selezneva, S. V. Glembotsky, S. V. Polyakov, M. N. Makarova, V. G. Makarov, A. A. Churin |
| |
| No 3 (2018) |
RECOMMENDATIONS OF THE EUROPEAN PHARMACOPOEIA «ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS» AND THEIR RESTRICTIONS FOR THE METHODS OF IMPURITIES DETERMINATION |
Abstract
PDF (Rus)
|
|
N. A. Epshtein, V. L. Sevastianova, A. I. Koroleva |
| |
| No 4 (2016) |
EXPERIENCE OF CERTIFICATION BIOANALYTICAL LABORATORY ACCORDING TO REQUIREMENTS OF GOST 33044-2014 «PRINCIPLES OF GOOD LABORATORY PRACTICE» (GLP) |
Abstract
PDF (Rus)
|
|
A. A. Krylatova, I. E. Shohin, E. P. Obrazcova, A. O. Monaenkov |
| |
| No 2 (2017) |
THE ANALYSIS OF THE ACTIVITIES OF THE CENTERS FOR THE DEVELOPMENT OF DRUGS, CREATED ON THE BASIS OF EDUCATIONAL ORGANIZATIONS |
Abstract
PDF (Rus)
|
|
A. A. Semin, I. A. Narkevich |
| |
| No 3 (2018) |
MODERN ASPECTS OF PATENT PRACTICE IN THE ACTIVITY OF THE SCIENTIFIC RESEARCH INSTITUTE |
Abstract
PDF (Rus)
|
|
A. I. Gromakova, E. V. Korol, O. A. Semkina |
| |
| No 4 (2016) |
REGULATORY STRATEGY OF CLINICAL DEVELOPMENT FOR FIXED COMBINATION MEDICINAL PRODUCTS |
Abstract
PDF (Rus)
|
|
K. A. Yatsenko, V. S. Berezina |
| |
| No 2 (2017) |
KEY TRENDS ANALYSIS OF RESULTS OBTAINED FROM INSPECTING THE FOREIGN MANUFACTURERS OF MEDICINAL PRODUCTS IN 2016 |
Abstract
PDF (Rus)
|
|
V. A. Orlov |
| |
| No 4 (2018) |
AN EXPERIENCE OF IMPLEMENTING LIMS SYSTEM IN THE BIOANALYTICAL LABORATORY (PART 1) |
Abstract
PDF (Rus)
|
|
A. A. Krylatova, I. E. Shohin, A. S. Kardashin |
| |
| 1 - 82 of 82 Items |
|
